Deutsche Bank Starts Climb Bio (CLYM) at Buy, 'Compelling Immunology Pipeline Led by IgAN'

October 20, 2026 7:13 AM EDT Send to a Friend
(Updated - October 20, 2026 7:14 AM EDT)

Deutsche Bank analyst David Hoang initiates coverage on Climb Bio (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login